AlphaGenome 2 unveiled to predict effects of DNA mutations in cells

Google DeepMind unveiled a next-generation AI model, AlphaGenome 2, that predicts the effects of DNA mutations for each cell type. It was trained on more than 100 million cell datasets, significantly improving the accuracy of predicting disease-related gene mutations. Non-profit use is available via API.

Why it mattersThis technological advance accelerates drug discovery and personalized medicine, directly affecting corporate R&D strategies.